Valuation: DexCom, Inc.

Market Cap 32.69B 583B 28.75B 27.18B 24.66B 46.31B 3,138B 46.58B 325B 126B 1,601B 123B 120B 5,145B P/E 2026 *
34.7x
P/E 2027 * 29.2x
Enterprise Value 31.93B 570B 28.08B 26.55B 24.08B 45.23B 3,065B 45.49B 318B 123B 1,564B 120B 117B 5,025B EV / Sales 2026 *
6.1x
EV / Sales 2027 * 5.45x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+0.48%
1 week+0.48%
Current month+0.48%
1 month+0.48%
3 months+23.72%
6 months+27.00%
Current year+26.65%
1 week 1,536.29
Extreme 1536.29
1,536.29
1 month 1,536.29
Extreme 1536.29
1,536.29
Current year 1,064.65
Extreme 1064.65
1,556.82
1 year 1,062.55
Extreme 1062.55
1,556.82
3 years 1,062.55
Extreme 1062.55
2,260
5 years 1,062.55
Extreme 1062.55
3,366.38
10 years 212.78
Extreme 212.775
3,366.38
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%+0.48% - - 32.69B
-0.30%-2.05%-24.22%+2.80% 175B
+0.89%-2.98%-5.27%+13.13% 113B
-1.05%-3.99%-1.37%+66.17% 58.57B
+0.20%+1.58%-0.24%-30.14% 50.07B
+0.45%+4.36%+15.64%+53.13% 49.92B
-0.14%-3.06%+30.06%-9.45% 32.69B
+1.28%+10.01% - - 30.44B
+1.67%+4.23%+44.86%-0.52% 26.07B
+1.98%+9.34%+26.26%-2.43% 23.55B
Average +0.52%+1.76%+10.72%+11.59% 62.22B
Weighted average by Cap. +0.25%+0.01%-2.61%+12.50%

Financials

2026 *2027 *
Net sales 5.23B 93.36B 4.6B 4.35B 3.95B 7.41B 502B 7.45B 52.08B 20.11B 256B 19.64B 19.21B 823B 5.8B 104B 5.1B 4.82B 4.38B 8.22B 557B 8.26B 57.75B 22.31B 284B 21.78B 21.3B 913B
Net income 974M 17.39B 857M 810M 735M 1.38B 93.53B 1.39B 9.7B 3.75B 47.73B 3.66B 3.58B 153B 1.15B 20.51B 1.01B 956M 867M 1.63B 110B 1.64B 11.44B 4.42B 56.28B 4.31B 4.22B 181B
Net Debt -761M -13.59B -669M -633M -574M -1.08B -73.06B -1.08B -7.58B -2.93B -37.28B -2.86B -2.8B -120B -1.06B -18.95B -934M -883M -801M -1.5B -102B -1.51B -10.57B -4.08B -51.99B -3.99B -3.9B -167B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.62USD
Average target price
94.48USD
Spread / Average Target
+9.07%

Quarterly revenue - Rate of surprise